Al Hammadi Company for Development and Investment reported a net profit after zakat of SAR 89.8 million for fiscal year 2018, a 16.8 percent year-on-year (YoY) decline on higher operating expenses and higher salaries driven by opening Nuzha Hospital in February last year.
The profit drop was also attributed by higher depreciation expenses and an increase in the cost of finance.
Item | 2017 | 2018 | Change |
---|---|---|---|
Revenues | 708.62 | 893.60 | 26.1 % |
Gross Income | 239.16 | 250.36 | 4.7 % |
Operating Income | 126.88 | 127.27 | 0.3 % |
Net Income | 107.97 | 89.81 | (16.8 %) |
Average Shares | 160.00 | 160.00 | - |
EPS (Riyals) | 0.67 | 0.56 | (16.8 %) |
Item | Q4 2017 | Q4 2018 | Change |
---|---|---|---|
Revenues | 188.69 | 228.04 | 20.9 % |
Gross Income | 65.08 | 65.32 | 0.4 % |
Operating Income | 33.93 | 29.53 | (13.0 %) |
Net Income | 30.76 | 17.70 | (42.5 %) |
Average Shares | 160.00 | 160.00 | - |
EPS (Riyals) | 0.19 | 0.11 | (42.5 %) |
Period | Revenues | Change | Gross Income | Change | Operating Income | Change |
---|---|---|---|---|---|---|
Q1 2018 | 200.67 | 11.3 % | 66.84 | 7.8 % | 38.29 | 13.9 % |
Q2 2018 | 214.49 | 21.4 % | 53.28 | (8.4 %) | 28.26 | (14.0 %) |
Q3 2018 | 250.40 | 53.6 % | 64.92 | 20.4 % | 31.19 | 17.9 % |
Q4 2018 | 228.04 | 20.9 % | 65.32 | 0.4 % | 29.53 | (13.0 %) |
2018 | 893.60 | 26.1 % | 250.36 | 4.7 % | 127.27 | 0.3 % |
Period | Net Income | Change | EPS(Riyal) | Extraordinary Income/Expense | Net Profit Before Unusual Items | EPS Before XO Items |
---|---|---|---|---|---|---|
Q1 2018 | 30.88 | 10.4 % | 0.19 | - | 30.88 | 0.19 |
Q2 2018 | 19.93 | (22.3 %) | 0.12 | - | 19.93 | 0.12 |
Q3 2018 | 21.31 | (9.7 %) | 0.13 | - | 21.31 | 0.13 |
Q4 2018 | 17.70 | (42.5 %) | 0.11 | - | 17.70 | 0.11 |
2018 | 89.81 | (16.8 %) | 0.56 | - | 89.81 | 0.56 |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
Q1 2018 | 33.46 % | 26.03 % | 15.21 % |
Q2 2018 | 31.18 % | 25.45 % | 13.71 % |
Q3 2018 | 29.28 % | 24.60 % | 12.04 % |
Q4 2018 | 28.02 % | 24.14 % | 10.05 % |
2018 | 28.02 % | 24.14 % | 10.05 % |
Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
---|---|---|---|---|
Q1 2018 | 160.00 | 0.69 | 0.69 | 8.85 |
Q2 2018 | 160.00 | 0.66 | 0.66 | 8.98 |
Q3 2018 | 160.00 | 0.64 | 0.64 | 9.11 |
Q4 2018 | 160.00 | 0.56 | 0.56 | 9.24 |
Period | P/E | Adjusted P/E | Price/book |
---|---|---|---|
Q1 2018 | 39.28 | 39.28 | 3.07 |
Q2 2018 | 37.68 | 37.68 | 2.76 |
Q3 2018 | 32.21 | 32.21 | 2.27 |
Q4 2018 | 33.55 | 33.55 | 2.04 |
Q4 2018
Period | healthy services and other | Pharmaceutical sales revenue - Pharmacies |
---|---|---|
Q1 2018 | 140.85 | 59.82 |
Q2 2018 | 143.64 | 71.39 |
Q3 2018 | 140.83 | 109.03 |
Q4 2018 | 154.81 | 73.23 |
Item | Q4 2018 (e) | Q4 2018 (a) | Change |
---|---|---|---|
Average | 23.38 | 17.70 | (24.3 %) |
Item | Q4 2018 (e) | Q4 2018 (a) | Change |
---|---|---|---|
Sico | 21.00 | 17.70 | (15.7) % |
AlJazira Capital | 22.50 | 17.70 | (21.3) % |
SNB Capital | 24.00 | 17.70 | (26.3) % |
Al Rajhi Capital | 26.00 | 17.70 | (31.9) % |
Current | |
Market Cap (M Riyal) | 6,144.00 |
Enterprise Value (EV) (M) | 5,905.92 |
Shares Outstanding ((M)) | 160.00 |
EPS ( Riyal) (TTM) | 2.04 |
Book Value (BV) ( Riyal) | 12.11 |
Par Value ( Riyal) | 10.00 |
Adjusted P/E (Last12) | 23.23 |
P/E (TTM) | 18.83 |
Price/book | 3.17 |
Return on Average Assets (%) (TTM) | 12.5 |
Return on Average Equity (%) (TTM) | 17.3 |
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}